ClassID:

95260

C07D405/12 - page 2 - CPC Classification

Classification description:

Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#301
20250084067
2025-03-13

PYRAZOLE-SUBSTITUTED CYCLOPENTANOL ESTER DERIVATIVE AND USE THEREOF

#302
20250084063
2025-03-13

BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS

#303
20250084048
2025-03-13

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

#304
20250084040
2025-03-13

SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS

#305
20250082609
2025-03-13

HETEROCYCLIC SULFONAMIDE DERIVATIVES AND PHARMACEUTICAL USES THEREOF

#306
20250081843
2025-03-06

ORGANIC COMPOUNDS AND ORGANIC LIGHT EMITTING DIODE COMPRISING THE SAME

#307
20250074902
2025-03-06

FUSED BICYCLIC HETEROARYL AMIDE COMPOUND AS PROTEIN AGGREGATION INHIBITOR

#308
20250074901
2025-03-06

NOVEL HETEROARYL COMPOUNDS

#309
20250074875
2025-03-06

AT2R ANTAGONISTS AND USES THEREOF

#310
20250074873
2025-03-06

COMPOUNDS

#311
20250073198
2025-03-06

COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IMPAIRED ß-GALACTOSIDASE ACTIVITY

#312
20250066410
2025-02-27

SUBSTITUTED 4-PHENYL PYRIDINE COMPOUNDS AS NON-SYSTEMIC TGR5 AGONISTS

#313
20250066344
2025-02-27

BENZOTHIAZOLE, BENZOISOXAZOLE, AND BENZODIOXOLE ANALOGS AS RXFP1 RECEPTOR AGONISTS

#314
20250066343
2025-02-27

NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION

#315
20250066335
2025-02-27

POLYSUBSTITUTED 4-HYDROXYPYRIDINE AND 4-HYDROXYQUINOLINE DERIVATIVES AS GPR84 ANTAGONISTS

#316
20250066309
2025-02-27

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#317
20250064840
2025-02-27

DRUG DELIVERY SYSTEMS BASED ON ENDOPEROXIDES USEFUL IN DIAGNOSIS AND THERAPY, AND METHODS THEREOF

#318
20250059182
2025-02-20

SOS1 INHIBITORS

#319
20250059180
2025-02-20

1,3-BENZODIOXOLE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

#320
20250059172
2025-02-20

INDAZOLE COMPOUND AND PHARMACEUTICAL

#321
20250059160
2025-02-20

Chemical Activators of Nicotinamide Mononucleotide adenylyltransferase 2 (NMNAT2) and Uses Thereof

#322
20250059159
2025-02-20

PLPRO INHIBITORS

#323
20250059141
2025-02-20

TLR MODULATOR AND USE THEREOF

#324
20250057850
2025-02-20

ERBB/BTK INHIBITORS

#325
20250051343
2025-02-13

INHIBITORS OF THE MYST FAMILY OF LYSINE ACETYL TRANSFERASES

#326
20250051290
2025-02-13

NOVEL COMPOUND FOR IMPROVING SLEEP OR USE THEREOF

#327
20250051282
2025-02-13

COMPOUNDS FOR TREATING POLYQ-RELATED NEURODEGENERATIVE DISORDERS

#328
20250051277
2025-02-13

DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS

#329
20250049791
2025-02-13

Synthesis of MEK7 Inhibitors and methods of Use Thereof

#330
20250042880
2025-02-06

DIAMINOBUTOXY-SUBSTITUTED ISOFLAVONOIDS AS MITOCHONDRIAL COMPLEX I INHIBITORS FOR CANCER TREATMENT

#331
20250042857
2025-02-06

SOS1 Inhibitor With Pyrido-Fused Six-Membered Ring Structure

#332
20250034121
2025-01-30

COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS

#333
20250034110
2025-01-30

LPAR1 ANTAGONISTS AND USES THEREOF

#334
20250034104
2025-01-30

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#335
20250034091
2025-01-30

Small molecule inhibitors of lanosterol synthase

#336
20250026740
2025-01-23

QUINOLINONE AMIDE COMPOUNDS AND USES THEREOF

#337
20250026726
2025-01-23

QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF

#338
20250026722
2025-01-23

SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS

#339
20250026721
2025-01-23

COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K

#340
20250025443
2025-01-23

COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES

#341
20250017940
2025-01-16

SELECTIVE PEPTIDOMIMETIC MODULATORS OF CAV2.2 (N-TYPE) VOLTAGE-GATED CALCIUM CHANNELS AND USES THEREOF

#342
20250011344
2025-01-09

PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF

#343
20250011310
2025-01-09

AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME

#344
20250011303
2025-01-09

SMALL MOLECULE MODULATORS OF IL-17A, METHODS OF MAKING AND METHODS OF USING THEREOF

#345
20250011289
2025-01-09

1H-BENZO[B]AZEPIN-2(3H)-ONE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER

#346
20250011288
2025-01-09

RXFP1 AGONISTS

#347
20250009889
2025-01-09

CYCLIC PEROXIDES AS PRODRUGS FOR SELECTIVE DELIVERY OF AGENTS

#348
20250008835
2025-01-02

Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device

#349
20250002480
2025-01-02

AMINOHETEROARYL KINASE INHIBITORS

#350
20250002469
2025-01-02

ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

#351
20250002448
2025-01-02

ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#352
20240425547
2024-12-26

PSMA Imaging Agents

#353
20240425487
2024-12-26

NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE

#354
20240425470
2024-12-26

SUBSTITUTED BENZOFURAN PROPYL AMINE MODULATORS OF MONOAMINERGIC TRANSPORTERS

#355
20240424105
2024-12-26

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

#356
20240423207
2024-12-26

PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY

#357
20240417397
2024-12-19

FLUORINE-CONTAINING PYRAZOLE COMPOUND AND PRODUCTION METHOD THEREFOR

#358
20240417385
2024-12-19

COMPOUND AND USE THEREOF FOR TREATING EMOTIONAL BEHAVIORAL DISORDERS

#359
20240417379
2024-12-19

P2X4 RECEPTOR ANTAGONIST

#360
20240409580
2024-12-12

PSMA Imaging Agents

#361
20240409517
2024-12-12

ORGANIC COMPOUNDS

#362
20240409509
2024-12-12

COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES

#363
20240409504
2024-12-12

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

#364
20240408064
2024-12-12

RAS INHIBITORS, COMPOSITIONS AND METHODS OF USE THEREOF

#365
20240400552
2024-12-05

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS

#366
20240400544
2024-12-05

N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDE ANALOGS AS MODULATORS OF SODIUM CHANNELS

#367
20240400543
2024-12-05

Methods for treating cancer

#368
20240400541
2024-12-05

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

#369
20240400502
2024-12-05

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

#370
20240398784
2024-12-05

C-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#371
20240391928
2024-11-28

COMPOSITIONS FOR THE TREATMENT OF FOOD AND CHEMICAL ADDICTION AND METHODS OF MAKING AND USING SAME

#372
20240391907
2024-11-28

Substituted tetrahydrofurans as modulators of sodium channels

#373
20240391882
2024-11-28

Substituted Quinoxalines

#374
20240391872
2024-11-28

PHENOXY-ACETYL-THIOUREIDO-BENZENESULFONAMIDE DERIVATIVES, AND THEIR USES

#375
20240389592
2024-11-28

FUNGICIDAL COMPOSITIONS

#376
20240383858
2024-11-21

MULTI-TARGETED TYROSINE KINASE INHIBITORS EFFECTIVE IN ANTITUMOR USES

#377
20240383856
2024-11-21

INHIBITORS OF TRANSGLUTAMINASES

#378
20240383851
2024-11-21

MATERIALS FOR ELECTRONIC DEVICES

#379
20240382498
2024-11-21

NOVEL INHIBITOR OF HYPE-MEDIATED AMPYLATION

#380
20240382486
2024-11-21

PYRIMIDINEDIONE COMPOUNDS

#381
20240382457
2024-11-21

BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS

#382
20240381766
2024-11-14

ORGANIC LIGHT EMITTING DEVICE

#383
20240376117
2024-11-14

IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE

#384
20240376084
2024-11-14

INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS

#385
20240376074
2024-11-14

NAMPT INHIBITORS AND USES THEREOF

#386
20240376068
2024-11-14

SIGMA LIGAND COMPOUNDS AND USES THEREOF

#387
20240376056
2024-11-14

PHENYL ACETAMIDE BASED IL-17A MODULATORS AND USES THEREOF

#388
20240376055
2024-11-14

INHIBITORS OF TRANSGLUTAMINASES

#389
20240374564
2024-11-14

NOVEL SEROTONIN DERIVATIVES AND THEIR USES FOR TREATING IRON-ASSOCIATED DISORDERS

#390
20240368184
2024-11-07

PIKfyve Inhibitors

#391
20240368172
2024-11-07

Cardiac sarcomere inhibitors

#392
20240368160
2024-11-07

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

#393
20240368147
2024-11-07

CYCLIN K DEGRADER

#394
20240368140
2024-11-07

CERTAIN PLADIENOLIDE COMPOUNDS AND METHODS OF USE

#395
20240368139
2024-11-07

NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF

#396
20240368137
2024-11-07

BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS

#397
20240368135
2024-11-07

SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS

#398
20240368131
2024-11-07

OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF

#399
20240368129
2024-11-07

SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS

#400
20240368113
2024-11-07

AMIDE COMPOUND AND USE THEREOF

#401
20240368109
2024-11-07

ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

#402
20240368106
2024-11-07

HYDROXY AND ALKOXY COUMARINS AS MODULATORS OF POLRMT

#403
20240366536
2024-11-07

MODULATORS OF A POTASSIUM CHANNEL AND OF TRPV1 CHANNEL AND USES THEREOF

#404
20240361688
2024-10-31

ONIUM SALT, RESIST COMPOSITION, AND PATTERN FORMING PROCESS

#405
20240360129
2024-10-31

Compounds for inhibiting NLRP3 and uses thereof

#406
20240360128
2024-10-31

Compounds for inhibiting NLRP3 and uses thereof

#407
20240360115
2024-10-31

COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION

#408
20240360108
2024-10-31

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

#409
20240360100
2024-10-31

HETEROCYCLIC COMPOUNDS AS SEROTONIN (5-HT) 5-HT2A AND 5-HT2C RECEPTOR POSITIVE ALLOSTERIC MODULATORS

#410
20240360085
2024-10-31

Glucose Uptake Inhibitors

#411
20240360081
2024-10-31

SULFONAMIDE OREXIN RECEPTOR AGONISTS AND USES THEREOF

#412
20240357924
2024-10-24

COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE

#413
20240351988
2024-10-24

ARYL HYDROCARBON RECEPTOR MODULATORS AND THEIR USE IN THE TREATMENT OF DISEASES AND DISORDERS

#414
20240351987
2024-10-24

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS

#415
20240351986
2024-10-24

UREA COMPOUND CONTAINING 2-HETEROAROMATIC RING SUBSTITUTION, PREPARATION METHOD THEREFOR AND USE THEREOF

#416
20240351984
2024-10-24

INDOLINE COMPOUNDS FOR INHIBITING KIF18A

#417
20240349605
2024-10-17

ORGANIC LIGHT EMITTING DEVICE

#418
20240349604
2024-10-17

ORGANIC LIGHT EMITTING DEVICE

#419
20240349598
2024-10-17

ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME

#420
20240343728
2024-10-17

COMPOUNDS THAT INHIBIT PI3K ISOFORM ALPHA AND METHODS FOR TREATING CANCER

#421
20240343714
2024-10-17

SOLID FORMS OF A DUAL RAF/MEK INHIBITOR

#422
20240343707
2024-10-17

SUBSTITUTED PHENYL ETHYNYL PYRIMIDINES AS POTENT INHIBITORS OF ALPHAVIRUSES

#423
20240343706
2024-10-17

PIPERIDINE-2,6-DIONE DERIVATIVES WHICH BIND TO CEREBLON, AND METHODS OF USE THEREOF

#424
20240336606
2024-10-10

SUBSTITUTED BENZO OR PYRIDOPYRIMIDINE AMINE INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

#425
20240336602
2024-10-10

Heterocycle derivatives for treating TRPM3 mediated disorders

#426
20240336594
2024-10-10

SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF

#427
20240336574
2024-10-10

METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE

#428
20240336571
2024-10-10

NOVEL CYCLOPROPYL COMPOUNDS

#429
20240336570
2024-10-10

Modulators of mas-related g-protein receptor X2 and related products and methods

#430
20240336562
2024-10-10

COMPOUND SERVING AS NLRP3 INHIBITOR

#431
20240335448
2024-10-10

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

#432
20240334818
2024-10-03

AROMATIC AMINE COMPOUNDS, AND COMPOSITIONS AND ORGANIC ELECTRONIC DEVICES INCLUDING THE SAME

#433
20240327707
2024-10-03

HETEROARYL-THIO-SUBSTITUTED PYRONES

#434
20240327393
2024-10-03

FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF

#435
20240327389
2024-10-03

LACTONE AND LACTAM CONTAINING COMPOUNDS USEFUL AS IMMUNOMODULATORS

#436
20240327388
2024-10-03

QUINOLINAMINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS

#437
20240327387
2024-10-03

TRIAZINE DERIVATIVES FOR THE TREATMENT OF TUMOURS AND NEURODEGENERATIVE DISORDERS

#438
20240327351
2024-10-03

AMIDE AND ETHER SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

#439
20240324451
2024-09-26

ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING SAME

#440
20240317729
2024-09-26

Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase

#441
20240317724
2024-09-26

3,4-METHYLENEDIOXYMETHAMPHETAMINE AND RELATED PSYCHEDELICS AND USES THEREOF

#442
20240317708
2024-09-26

INHIBITORS OF TRANSGLUTAMINASES

#443
20240317689
2024-09-26

POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION

#444
20240316020
2024-09-26

Novel Pyridine Compounds

#445
20240315130
2024-09-19

HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

#446
20240308965
2024-09-19

1,3-SUBSTITUTED CYCLOBUTYL DERIVATIVES AND USES THEREOF

#447
20240308964
2024-09-19

PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

#448
20240300968
2024-09-12

6-SUBSTITUTED NAPHTHALENE-1,3-DISULFONIC ACID DERIVATIVES AS MODULATORS OF THE EXTRACELLULAR NICOTINAMIDE PHOSPHORIBOSYL TRANSFERASE (ENAMPT) FOR THE TREATMENT OF E.G. DIABETES

#449
20240300903
2024-09-12

BENZOMIDAZOL-1,2-YL AMDES AS Kv7 CHANNEL ACTIVATORS

#450
20240300898
2024-09-12

FUSED PIPERIDINYL BICYCLIC AND RELATED COMPOUNDS AS MODULATORS OF C5A RECEPTOR

#451
20240300892
2024-09-12

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer

#452
20240299402
2024-09-12

MODULATORS OF HSD17B13 AND METHODS OF USE THEREOF

#453
20240299385
2024-09-12

3-PYRROLYLSULFONAMIDE COMPOUNDS AS GPR17 ANTAGONISTS

#454
20240299371
2024-09-12

BIARYL AMIDE AND HETEROARYL AMIDES FOR TREATMENT OF CANDIDA ALBICANS INFECTION

#455
20240294513
2024-09-05

PYRANONE COMPOUNDS USEFUL TO MODULATE OMA1 PROTEASE

#456
20240294512
2024-09-05

HYDROXY AND (HALO)ALKOXY SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS

#457
20240292840
2024-09-05

TRIAZOLE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS

#458
20240287051
2024-08-29

PROCESS FOR PREPARING AN ERK INHIBITOR

#459
20240287048
2024-08-29

SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER

#460
20240285597
2024-08-29

Fused ring compound having urea structure

#461
20240279209
2024-08-22

Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins

#462
20240279208
2024-08-22

Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide

#463
20240279196
2024-08-22

ORGANIC COMPOUND AND ORANIC LIGHT-EMITTING DIODE COMPRISING SAME BACKGROUND OF THE INVENTION

#464
20240279187
2024-08-22

COMPOUNDS, DEVICES, AND USES THEREOF

#465
20240279184
2024-08-22

HETEROAROMATIC ANALOGUES OF 3-BENZYLMENADIONE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION

#466
20240279174
2024-08-22

ANTIBIOTICS COMPRISING LPXH-TARGETING COMPOUNDS AND METHODS OF MAKING AND USING THE SAME

#467
20240277723
2024-08-22

Aryl-or heteroaryl-substituted benzene compounds

#468
20240277701
2024-08-22

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

#469
20240276872
2024-08-15

PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME

#470
20240270725
2024-08-15

MAGL INHIBITORS

#471
20240270717
2024-08-15

COMPOUNDS AND METHODS FOR TARGETING PATHOGENIC BLOOD VESSELS

#472
20240270697
2024-08-15

HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

#473
20240262831
2024-08-08

COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS

#474
20240262829
2024-08-08

PEPTIDE NUCLEIC ACIDS, SYNTHESIS, AND USES THEREOF

#475
20240262812
2024-08-08

N-SUBSTITUTED PHENYLSULFONAMIDE COMPOUND AND USE THEREOF

#476
20240262794
2024-08-08

COMPOUNDS FOR TREATING CONDITIONS RELATED TO OXIDATIVE STRESS

#477
20240262793
2024-08-08

QUINAZOLINE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#478
20240262792
2024-08-08

USP30 INHIBITORS AND USES THEREOF

#479
20240260453
2024-08-01

Organic Light-Emitting Compound And Organic Light-Emitting Device Comprising Same

#480
20240254111
2024-08-01

SUBSTITUTED BENZAMIDES AS HERBICIDES

#481
20240254110
2024-08-01

FUSED 1,4-DIHYDRODIOXIN DERIVATIVES AS INHIBITORS OF HEAT SHOCK TRANSCRIPTION FACTOR 1

#482
20240254109
2024-08-01

SALT CONTAINING PIPERAZINE POLYCYCLIC DERIVATIVE, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF

#483
20240254094
2024-08-01

HERBICIDAL COMPOUNDS

#484
20240254090
2024-08-01

COMPOUNDS WITH ARYLAMINE STRUCTURES

#485
20240252655
2024-08-01

DEUBIQUITINASE-TARGETING CHIMERAS AND RELATED METHODS

#486
20240252492
2024-08-01

GPCR RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND METHODS FOR THEIR USE

#487
20240251667
2024-07-25

ORGANIC COMPOUND, OPTICAL DEVICE, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC DEVICE, AND LIGHTING DEVICE

#488
20240251666
2024-07-25

HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND COMPOSITION FOR ORGANIC MATERIAL LAYER COMPRISING THE SAME

#489
20240251665
2024-07-25

TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT

#490
20240246941
2024-07-25

SUBSTITUTED 4-(3-AMINOPROP-1-YL)AMINOQUINOLINE ANALOGS AS MODULATORS OF MELANOMA-ASSOCIATED ANTIGEN 11 UBIQUITIN LIGASE

#491
20240246922
2024-07-25

ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY

#492
20240246910
2024-07-25

Delivery of therapeutic alkaloid compounds

#493
20240246909
2024-07-25

EBNA1 Inhibitors and Methods Using Same

#494
20240246908
2024-07-25

TEAD INHIBITORS

#495
20240246901
2024-07-25

GPX4 INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR USE FOR TREATING GPX4-MEDIATED DISEASES

#496
20240245698
2024-07-25

Aryl-OR heteroaryl-substituted benzene compounds

#497
20240245697
2024-07-25

Aryl-or heteroaryl-substituted benzene compounds

#498
20240245673
2024-07-25

Papain-like protease (PLpro) inhibitors

#499
20240239806
2024-07-18

COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS

#500
20240239775
2024-07-18

FXR REGULATOR, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF

#501
20240239758
2024-07-18

SUBSTITUTED TRIAZINE COMPOUND

#502
20240239752
2024-07-18

BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5

#503
20240239747
2024-07-18

Next Generation 5-HT2AR Agonists

#504
20240217942
2024-07-04

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#505
20240217930
2024-07-04

SARS-COV-2 MPRO INHIBITOR COMPOUNDS

#506
20240215441
2024-06-27

ORGANIC LIGHT EMITTING DEVICE

#507
20240215281
2024-06-27

COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE

#508
20240208950
2024-06-27

COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL AND OVARIAN CANCER

#509
20240208927
2024-06-27

WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE

#510
20240208909
2024-06-27

SUBSTITUTED QUINOLINE DERIVATIVES HAVING SOS1 INHIBITION ACTIVITIES AND USES THEREOF

#511
20240208905
2024-06-27

ABIRATERONE DERIVATIVE, PREPARATION AND APPLICATION THEREOF

#512
20240199638
2024-06-20

GLUTARIMIDES FOR MEDICAL TREATMENT

#513
20240199636
2024-06-20

Inhibitors of RAD52 Recombination Protein and Methods Using Same

#514
20240199606
2024-06-20

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

#515
20240199592
2024-06-20

Chromene derivatives as inhibitors of TCR-Nck interaction

#516
20240199591
2024-06-20

SELECTIVE LIGANDS FOR MODULATION OF GIRK CHANNELS

#517
20240197752
2024-06-20

SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY

#518
20240190846
2024-06-13

Thyroid hormone receptor agonists and use thereof

#519
20240190824
2024-06-13

INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTION

#520
20240190821
2024-06-13

SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF

#521
20240189304
2024-06-13

BET PROTEIN INHIBITORS AND USE THEREOF

#522
20240188424
2024-06-06

ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME

#523
20240182490
2024-06-06

BROMODOMAIN INHIBITORS

#524
20240182460
2024-06-06

ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE

#525
20240182455
2024-06-06

N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels

#526
20240182426
2024-06-06

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

#527
20240180916
2024-06-06

Theramutein modultors

#528
20240174685
2024-05-30

OX2R Compounds

#529
20240174676
2024-05-30

Pyrazolopyrimidine compounds as kinase Inhibitors

#530
20240174668
2024-05-30

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

#531
20240174659
2024-05-30

COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR

#532
20240174650
2024-05-30

8-(PICOLINAMIDE) SUBSTITUTED COUMARIN COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

#533
20240174636
2024-05-30

NOVEL INDOLEAMINE 2,3-DIOXYGENASE INHIBITORS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

#534
20240174610
2024-05-30

Substituted piperidine compound and use thereof

#535
20240173307
2024-05-30

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#536
20240172556
2024-05-23

ORGANIC ELECTRIC ELEMENT USING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF

#537
20240166636
2024-05-23

CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME

#538
20240166635
2024-05-23

AMINOHETEROARYL KINASE INHIBITORS

#539
20240166617
2024-05-23

PHOSPHOINOSITIDE 3 KINASE BETA INHIBITORS AND COMPOSITIONS AND METHODS THEREOF

#540
20240166606
2024-05-23

MULTI-TARGETED TYROSINE KINASE INHIBITORS AND THEIR PHARMACEUTICAL USES

#541
20240165121
2024-05-23

SUBSTITUTED BENZENE COMPOUNDS

#542
20240158402
2024-05-16

METHODS FOR INHIBITING FASCIN

#543
20240158383
2024-05-16

RIBONUCLEOTIDE REDUCTASE (RNR) INHIBITORS AND USES THEREOF

#544
20240158376
2024-05-16

Methods for treating cancer

#545
20240158375
2024-05-16

COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS

#546
20240158372
2024-05-16

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

#547
20240158356
2024-05-16

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

#548
20240158350
2024-05-16

ESTER ANALOGS OF PSILOCIN, PROCESSES FOR THE PREPARATION THEREOF, AND METHODS OF USE

#549
20240156851
2024-05-16

Catecholamine prodrugs for use in the treatment of Parkinson's disease

#550
20240150331
2024-05-09

ACID ADDITION SALTS OF BENZIMIDAZOLE DERIVATIVE

#551
20240150318
2024-05-09

PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS

#552
20240150316
2024-05-09

Bicyclic carboxamides and methods of use thereof

#553
20240150311
2024-05-09

COMPOSITIONS AND METHODS FOR INHIBITING IDO1

#554
20240150301
2024-05-09

METHODS OF MODULATING ANDROGEN RECEPTOR CONDENSATES

#555
20240150296
2024-05-09

Human plasma kallikrein inhibitors

#556
20240150295
2024-05-09

Human plasma kallikrein inhibitors

#557
20240150284
2024-05-09

Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds, Processes for their Preparation and Therapeutic Uses Thereof

#558
20240148744
2024-05-09

SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES

#559
20240140940
2024-05-02

CARBOXYLIC ACID, ACYL SULFONAMIDE AND ACYL SULFAMIDE-DERIVATIZED BICYCLIC AZA-HETEROAROMATICS AS SELECTIVE MCL-1 INHIBITORS AND AS DUAL MCL-1/BCL-2 INHIBITORS

#560
20240140936
2024-05-02

METHOD FOR THE PREPARATION OF PYRAZOLE DERIVATIVES AS MODULATORS OF CFTR PROTEIN

#561
20240139194
2024-05-02

PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS

#562
20240139152
2024-05-02

HBV INHIBITOR AND ITS USE

#563
20240132485
2024-04-25

HETEROCYCLIC CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF

#564
20240132480
2024-04-25

INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE

#565
20240132461
2024-04-25

FLAVONE DEAZA SPERMIDINE ANALOGUES AND THEIR USE TREATING CANCER

#566
20240124466
2024-04-18

COMPOUNDS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE, DEGENERATIVE AND METABOLIC DISORDERS

#567
20240124449
2024-04-18

Compounds and methods for inhibiting fascin

#568
20240124448
2024-04-18

TYK2 inhibitors and compositions and methods thereof

#569
20240124434
2024-04-18

ATF6 INHIBITORS AND USES THEREOF

#570
20240124413
2024-04-18

COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS

#571
20240124406
2024-04-18

INHIBITORS OF TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) AND USES THEREOF

#572
20240116907
2024-04-11

FUSED HETEROCYCLIC MESCALINE DERIVATIVES

#573
20240116905
2024-04-11

MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF

#574
20240116894
2024-04-11

PROTEASOME ACTIVITY ENHANCING COMPOUNDS

#575
20240116877
2024-04-11

KIT KINASE INHIBITORS AND METHODS OF USE THEREOF

#576
20240116875
2024-04-11

RATIONAL DESIGN, OPTIMIZATION, AND BIOLOGICAL EVALUATION OF NOVEL MEK4 INHIBITORS AGAINST PANCREATIC ADENOCARCINOMA

#577
20240116872
2024-04-11

PYRIDYL INHIBITORS FOR HEDGEHOG SIGNALLING

#578
20240114942
2024-04-11

Antagonists of T2R54 and compositions and uses thereof

#579
20240114908
2024-04-11

2,6-DIOXO-3,6-DIHYDROPYRIMIDINE COMPOUND, AGRICULTURAL AND HORTICULTURAL BACTERICIDE, NEMATICIDE, AND MEDICAL AND VETERINARY ANTIFUNGAL AGENT

#580
20240114775
2024-04-04

Nitrogen-containing compound, and electronic element and electronic device comprising same

#581
20240109905
2024-04-04

4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3

#582
20240109889
2024-04-04

DIHYDROBENZIMIDAZOLONES FOR MEDICAL TREATMENT

#583
20240109860
2024-04-04

HETEROCYCLIC COMPOUNDS AS PESTICIDES

#584
20240109842
2024-04-04

ACRYLAMIDE COMPOUNDS

#585
20240101584
2024-03-28

TARGETED DELIVERY OF 1,2,4,5 TETRAOXANE COMPOUNDS AND THEIR USES

#586
20240101539
2024-03-28

Potent ASGPR-binding compounds for the degradation of immunoglobulins and other proteins

#587
20240101538
2024-03-28

PROTEIN-PROTEIN INTERACTION MODULATORS OF AURORA KINASE A AND THEIR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER

#588
20240101518
2024-03-28

MCT4 inhibitors for treating disease

#589
20240092776
2024-03-21

HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME

#590
20240092770
2024-03-21

Heterocycle RMB39 Modulators

#591
20240092766
2024-03-21

MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS

#592
20240090322
2024-03-14

MATERIALS FOR ELECTRONIC DEVICES

#593
20240084065
2024-03-14

NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND

#594
20240083885
2024-03-14

COMPOSITIONS AND METHODS FOR INHIBITING M PRO PROTEASE ACTIVITY AND FOR PREVENTING AND TREATING SARS-COV-2 INFECTION

#595
20240083872
2024-03-14

CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY

#596
20240083871
2024-03-14

DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#597
20240083866
2024-03-14

PRODRUGS OF TETRAHYDROCANNABINOL COMPOSITIONS COMPRISING PRODRUGS OF TETRAHYDROCANNABINOL AND METHODS OF USING THE SAME

#598
20240083857
2024-03-14

2-Methyl-Quinazolines

#599
20240083854
2024-03-14

TEAD INHIBITORS AND USES THEREOF

#600
20240081148
2024-03-07

ORGANIC LIGHT EMITTING DEVICE